Chronicity Counts: The Impact of P. aeruginosa, S. aureus, and Co-Infection in Cystic Fibrosis

Am J Respir Crit Care Med. 2024 Feb 29. doi: 10.1164/rccm.202312-2326LE. Online ahead of print.

Micaela Mossop^{1

2}, Jonathan Ish-Horowicz³, Dominic Hughes^{4

5}, Rebecca Dobra², Alessandra G Cunanan³, Mark Rosenthal², Siobhán B Carr², Newara Ramadan², Laura M Nolan^{6

3}, Jane C Davies^{7

8}

¹ Imperial College London, 4615, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.
² Royal Brompton and Harefield Hospitals, 4964, London, United Kingdom of Great Britain and Northern Ireland.
³ Imperial College London National Heart and Lung Institute, 90897, London, United Kingdom of Great Britain and Northern Ireland.
⁴ King's College Hospital NHS Foundation Trust, 8948, Paediatric Respiratory Medicine, London, United Kingdom of Great Britain and Northern Ireland.
⁵ Imperial College London, 4615, National heart and lung institute, London, United Kingdom of Great Britain and Northern Ireland.
⁶ Quadram Institute Bioscience, 7308, Norwich, Norfolk, United Kingdom of Great Britain and Northern Ireland.
⁷ Imperial College London, National Heart and Lung Institute, London, United Kingdom of Great Britain and Northern Ireland.
⁸ Royal Brompton and Harefield Hospitals, 4964, London, United Kingdom of Great Britain and Northern Ireland; j.c.davies@imperial.ac.uk.

No abstract available

Keywords: Pseudomonas aeruginosa; Staphylococcus aureus; Cystic Fibrosis; Epidemiology; Pulmonary infections.